# Rani Therapeutics Holdings, Inc.: Form 8-K, filed Oct 17, 2025

- Company: [Rani Therapeutics Holdings, Inc.](/companies/rani.md) (CIK 1856725)
- Form: 8-K
- Filed: 2025-10-17
- Accepted by EDGAR: Oct 17, 2025, 07:38 ET
- Period: 2025-10-16
- Accession: 0001193125-25-241963
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1856725/000119312525241963/d38236d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1856725/000119312525241963/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1856725/000119312525241963/d38236d8k.htm

Filed Oct 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-241963. Last ingested by Listed: Nov 10, 2026, 04:23 ET. No prices; not investment advice.